| Less than twenty years ago photolithography and medicine were total strangers to one another. They had not yet met, and not even looking each other up in the classifieds. And then, nucleic acid chips, microfluidics and microarrays entered the scene, and rapidly these strangers became indispensable partners in biomedicine. As recently as ten years ago the notion of applying nanotechnology to the fight against disease was dominantly the province of the fiction writers. Thoughts of nanoparticle-vehicled delivery of therapeuticals to diseased sites were an exercise in scientific solitude, and grounds for questioning one’s ability to think “like an established scientist”. And today we have nanoparticulate paclitaxel as the prime option against metastatic breast cancer, proteomic profiling diagnostic tools based on target surface nanotexturing, nanoparticle contrast agents for all radiological modalities, nanotechnologies embedded in high-distribution laboratory equipment, and no less than 152 novel nanomedical entities in the regulatory pipeline in the US alone. This is a transforming impact, by any measure, with clear evidence of further acceleration, supported by very vigorous investments by the public and private sectors throughout the world. Even joining the dots in a most conservative, linear fashion, it is easy to envision scenarios of personalized medicine such as the following: patient-specific prevention supplanting gross |
المواضيع الأخيرة
faceook
find us on facebook
Time now
أفضل 10 أعضاء في هذا المنتدى
تدفق ال 
التبادل الاعلاني
تقنية النانو ^^english
trojan- متميز عم يشتغل على حالو
- عدد المساهمات : 39
نقاط : 5237
يا عيني : 3
تاريخ التسجيل : 21/11/2010
مواضيع مماثلة
» معلومات مهمة أغلبكم لا يعرفها
» معلومات مهمة أغلبكم لا يعرفها
» معلومات مهمة أغلبكم لا يعرفها
» سؤال جميل جداً..لماذا لا تحترق الحجارة؟
» مهارات وذوقيات لنرتقي بمجتمعنا
» بخل وراثي جدا
» النكتة اليابانية الأمريكية
» أفكار محشش.هل تكون واقعية؟